Clinical Trial Update: Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia

View source ↗

Summary

An update on a clinical trial investigating risk factors for concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Carcinoma
• Endometrial Hyperplasia

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Endometrial Carcinoma | Status: UNKNOWN